Canopy Growth Corporation (WEED.TO)
CAD 1.85
(-4.64%)
CAD 1.85
(-4.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 799.82 Million CAD | -52.37% |
| 2022 | 1.67 Billion CAD | -15.39% |
| 2021 | 1.98 Billion CAD | -38.01% |
| 2020 | 3.2 Billion CAD | 90.59% |
| 2019 | 1.67 Billion CAD | 12.72% |
| 2018 | 1.49 Billion CAD | 669.9% |
| 2017 | 193.57 Million CAD | 207.91% |
| 2016 | 62.86 Million CAD | 221.15% |
| 2015 | 19.57 Million CAD | 355.84% |
| 2014 | 4.29 Million CAD | 225.28% |
| 2013 | 1.32 Million CAD | 12120.1% |
| 2012 | 10.8 Thousand CAD | 18.21% |
| 2011 | 9140.00 CAD | 38.23% |
| 2010 | 6612.00 CAD | -13.39% |
| 2009 | 7634.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 753.3 Million CAD | -5.82% |
| 2023 Q3 | 815.08 Million CAD | -11.28% |
| 2023 Q4 | 799.82 Million CAD | -1.87% |
| 2023 FY | 799.82 Million CAD | -52.37% |
| 2023 Q1 | 1.34 Billion CAD | -20.01% |
| 2023 Q2 | 918.76 Million CAD | -31.59% |
| 2022 Q1 | 1.83 Billion CAD | -7.56% |
| 2022 Q2 | 1.73 Billion CAD | -5.25% |
| 2022 Q3 | 1.58 Billion CAD | -9.08% |
| 2022 FY | 1.67 Billion CAD | -15.39% |
| 2022 Q4 | 1.67 Billion CAD | 6.24% |
| 2021 Q3 | 2.09 Billion CAD | -3.6% |
| 2021 FY | 1.98 Billion CAD | -38.01% |
| 2021 Q4 | 1.98 Billion CAD | -5.38% |
| 2021 Q2 | 2.17 Billion CAD | -19.0% |
| 2021 Q1 | 2.68 Billion CAD | -16.1% |
| 2020 Q1 | 1.58 Billion CAD | -5.73% |
| 2020 Q2 | 1.42 Billion CAD | -10.29% |
| 2020 Q3 | 2.01 Billion CAD | 41.74% |
| 2020 FY | 3.2 Billion CAD | 90.59% |
| 2020 Q4 | 3.2 Billion CAD | 59.0% |
| 2019 Q2 | 2.6 Billion CAD | -5.44% |
| 2019 Q4 | 1.67 Billion CAD | -33.24% |
| 2019 Q3 | 2.51 Billion CAD | -3.32% |
| 2019 Q1 | 2.75 Billion CAD | 84.68% |
| 2019 FY | 1.67 Billion CAD | 12.72% |
| 2018 Q2 | 1.13 Billion CAD | 27.91% |
| 2018 FY | 1.49 Billion CAD | 669.9% |
| 2018 Q4 | 1.49 Billion CAD | 22.52% |
| 2018 Q3 | 1.21 Billion CAD | 7.11% |
| 2018 Q1 | 887.85 Million CAD | 358.65% |
| 2017 FY | 193.57 Million CAD | 207.91% |
| 2017 Q4 | 193.57 Million CAD | 157.11% |
| 2017 Q3 | 75.29 Million CAD | 12.18% |
| 2017 Q2 | 67.11 Million CAD | 10.38% |
| 2017 Q1 | 60.8 Million CAD | -3.28% |
| 2016 Q3 | 29.14 Million CAD | 18.53% |
| 2016 FY | 62.86 Million CAD | 221.15% |
| 2016 Q2 | 24.58 Million CAD | 23.84% |
| 2016 Q4 | 62.86 Million CAD | 115.74% |
| 2016 Q1 | 19.85 Million CAD | 1.41% |
| 2015 Q3 | 17.49 Million CAD | 51.44% |
| 2015 Q4 | 19.57 Million CAD | 11.87% |
| 2015 FY | 19.57 Million CAD | 355.84% |
| 2015 Q1 | 6.83 Million CAD | 7.43% |
| 2015 Q2 | 11.55 Million CAD | 68.99% |
| 2014 Q2 | 2.18 Million CAD | -30.3% |
| 2014 Q4 | 6.36 Million CAD | 48.21% |
| 2014 Q3 | 4.29 Million CAD | 96.38% |
| 2014 Q1 | 3.13 Million CAD | 12.99% |
| 2014 FY | 4.29 Million CAD | 225.28% |
| 2013 Q2 | 11.05 Thousand CAD | 2.31% |
| 2013 Q3 | 2438.00 CAD | -77.94% |
| 2013 Q4 | 2.77 Million CAD | 113794.75% |
| 2013 FY | 1.32 Million CAD | 12120.1% |
| 2013 Q1 | 10.8 Thousand CAD | 535.53% |
| 2012 Q2 | 6500.00 CAD | -28.88% |
| 2012 Q4 | 1700.00 CAD | 19.47% |
| 2012 Q3 | 1423.00 CAD | -78.11% |
| 2012 Q1 | 9140.00 CAD | 41.05% |
| 2012 FY | 10.8 Thousand CAD | 18.21% |
| 2011 FY | 9140.00 CAD | 38.23% |
| 2011 Q4 | 6480.00 CAD | -40.77% |
| 2011 Q3 | 10.94 Thousand CAD | 7.23% |
| 2011 Q2 | 10.2 Thousand CAD | 54.3% |
| 2011 Q1 | 6612.00 CAD | 25.87% |
| 2010 Q1 | 7634.00 CAD | -75.34% |
| 2010 FY | 6612.00 CAD | -13.39% |
| 2010 Q4 | 5253.00 CAD | 34.66% |
| 2010 Q3 | 3901.00 CAD | 7.47% |
| 2010 Q2 | 3630.00 CAD | -52.45% |
| 2009 Q4 | 30.96 Thousand CAD | 0.0% |
| 2009 FY | 7634.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aurora Cannabis Inc. | 236.8 Million CAD | -237.759% |
| Avicanna Inc. | 13.99 Million CAD | -5613.431% |
| Avant Brands Inc. | 33.22 Million CAD | -2307.365% |
| Cardiol Therapeutics Inc. | 8.45 Million CAD | -9360.881% |
| Crescita Therapeutics Inc. | 5.77 Million CAD | -13747.351% |
| Knight Therapeutics Inc. | 198.62 Million CAD | -302.686% |
| MediPharm Labs Corp. | 10.93 Million CAD | -7216.347% |
| OrganiGram Holdings Inc. | 26.83 Million CAD | -2880.855% |
| Willow Biosciences Inc. | 3.23 Million CAD | -24608.774% |
| Auxly Cannabis Group Inc. | 210.85 Million CAD | -279.32% |